The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease
R. Borie, B. Crestani, P. Dieude, H. Nunes, Y. Allanore, C. Kannengiesser, P. Airo, M. Matucci-Cerinic, B. Wallaert, D. Israel-Biet, J. Cadranel, V. Cottin, D. Valeyre, B. Grandchamp (Paris, Bobigny, Lyon, Lille, France; Brescia, Italy)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Session: Idiopathic pulmonary fibrosis
Session type: Poster Discussion
Number: 3145
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Borie, B. Crestani, P. Dieude, H. Nunes, Y. Allanore, C. Kannengiesser, P. Airo, M. Matucci-Cerinic, B. Wallaert, D. Israel-Biet, J. Cadranel, V. Cottin, D. Valeyre, B. Grandchamp (Paris, Bobigny, Lyon, Lille, France; Brescia, Italy). The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease. Eur Respir J 2012; 40: Suppl. 56, 3145
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes Source: Eur Respir J, 50 (3) 1700537; 10.1183/13993003.00537-2017 Year: 2017
The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis Source: Eur Respir J, 55 (4) 1902361; 10.1183/13993003.02361-2019 Year: 2020
Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006
IL-1α gene polymorphism in pulmonary sarcoidosis in relation to disease severity Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002
CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis Source: Eur Respir J 2010; 35: 324-330 Year: 2010
Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Source: Eur Respir J 2008; 32: 1004-1008 Year: 2008
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008
The functional polymorphisms in the IL-18 gene promoter is associated with the pathogenesis of sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003
To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006
MUC5B is expressed by bronchoalveolar epithelia and is associated with ER stress in idiopathic pulmonary fibrosis and rheumatoid arthritis associated interstitial lung disease Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018
A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 148s Year: 2006
VNTR polymorphism NOS3 gene among chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019
MUC5B genotype affects survival of patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019
Effect of MUC5B gene polymorphism on survival in a Lebanese population of patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
IL-13 polymorphism: predisposition towards COPD and asbestos-induced diseases Source: Eur Respir J 2001; 18: Suppl. 33, 535s Year: 2001
The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis Source: Eur Respir J 2011; 38: 1355-1360 Year: 2011
TNF gene polymorphisms and asthma development in cystic fibrosis patients Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010
IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007